Cite
HARVARD Citation
Cohen, S. et al. (n.d.). Item‐level analysis of clinical measures in patients with early symptomatic Alzheimer's disease following treatment with high‐dose aducanumab in the phase 3 study EMERGE. Alzheimer's & dementia. p. n/a. [Online].